Hypoxia-Triggered Transforming Immunomodulator for Cancer Immunotherapy via Photodynamically Enhanced Antigen Presentation of Dendritic Cell
- 18 December 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 13 (1) , 476-488
Abstract
A key factor for successful cancer immunotherapy (CIT) is the extent of antigen presentation by dendritic cells (DCs) that phagocytize tumor-associated antigens (TAA) in the tumor site and migrate to tumor draining lymph nodes (TDLN), for the activation of T cells. Although various types of adjuvant delivery have been studied to enhance the activity of the DCs, poor delivery efficiency and depleted population of tumor infiltrating DCs have limited the efficacy of CIT. Herein, we report a hypoxia-responsive mesoporous silica nanocarrier (denoted as CAGE) for an enhanced CIT assisted by photodynamic therapy (PDT). In this study, CAGE was designed as a hypoxia-responsive transforming carrier to improve the intracellular uptake of nanocarriers and the delivery of adjuvants to DCs. Furthermore, PDT was exploited for the generation of immunogenic debris and recruitment of DCs in a tumor site, followed by enhanced antigen presentation. Finally, a significant inhibition of tumor growth was observed in vivo, signifying that the PDT would be a promising solution for DC-based immunotherapyKeywords
Funding Information
- National Research Foundation of Korea (NRF-2017M3A9F5030930, NRF-2017R1E1A1A01074088, NRF-2018M3D1A1058813)
This publication has 63 references indexed in Scilit:
- Dye Sensitizers for Photodynamic TherapyMaterials, 2013
- Mesoporous silica nanoparticle facilitated drug release through cascade photosensitizer activation and cleavage of singlet oxygen sensitive linkerChemical Communications, 2012
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Synthesis of New Azo Compounds Based on N-(4-Hydroxypheneyl)maleimide and N-(4-Methylpheneyl)maleimideMolecules, 2010
- Hypoxia-specific targets in cancer therapy: role of splice variantsBMC Medicine, 2010
- Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxisProceedings of the National Academy of Sciences, 2010
- Impact of class A, B and C CpG‐oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus‐1 infected individualsImmunology, 2007
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Poly(organophosphazenes) with Chromophores as Substituent GroupsMacromolecules, 1978